Drug costs to patients too high and complex: Consumers Health Forum

Stacks of gold coins
The Grattan Institute report into pharmaceutical premium pricing policy highlights “unnecessarily high” costs to patients and taxpayers of a health system it describes as complex and labyrinthine, says the Consumers Health Forum CEO, Leanne Wells. “We accept the drug industry’s need for a reasonable profit to develop new drugs, but this report exposes a pricing

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Integrate self care into health policy: report
Next Grattan Institute 'misses the point' on pricing: Medicines Australia